SCHEMBL7362770

SCHEMBL7362770

C[C](c1ccc2ccccc2c1)c1c[nH]cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 2/20 0.40
F2 P00734 1/20 0.39
PLG P00747 1/20 0.39
PLAU P00749 1/20 0.39
KLKB1 P03952 1/20 0.39
KLK1 P06870 1/20 0.39
PRSS1 P07477 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
MAPT P10636 3/20 0.38
MAPK1 P28482 2/20 0.38
TSHR P16473 1/20 0.37
ALDH1A1 P00352 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5750943 0.81 MEN1 (0.51) CES2CES1SMN1; SMN2HPGDKDM4E
SCHEMBL8708792 0.76 SMN1; SMN2 (0.52) CES2CES1SMN1; SMN2HPGDKDM4E
SCHEMBL9669231 0.69 NPC1 (0.43) CES2CES1SMN1; SMN2HPGDKDM4E
SCHEMBL5678286 0.68 KDM4E (0.53) HPGDKDM4EPLAUKMT2AMEN1
SCHEMBL397225 0.67 CES2 (0.60) CES2CES1SMN1; SMN2HPGDKDM4E
SCHEMBL5678124 0.67 CYP1A2 (0.44) KDM4EMAPTTSHRALDH1A1CYP3A4
SCHEMBL1374762 0.65
SCHEMBL4526053 0.65 CYP11B1 (0.50) SMN1; SMN2HPGDKDM4EKMT2AMEN1
SCHEMBL23421115 0.65 PBRM1 (0.53) SMN1; SMN2KDM4EKMT2AMEN1MAPT
SCHEMBL43058 0.64 ALDH1A1 (0.71) CES2CES1SMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1990005531-A1 METHOD FOR TREATING VASCULAR DISEASES ABBOTT LABORATORIES (US) 1990-05-31 WO disclosed